Page last updated: 2024-11-04

vorinostat and Cancer of Gallbladder

vorinostat has been researched along with Cancer of Gallbladder in 3 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, S1
Li, F1
Pan, L1
Yang, Z1
Shu, Y1
Lv, W1
Dong, P1
Gong, W1
Zhang, P2
Guo, Z1
Wu, Y1
Hu, R1
Du, J2
He, X1
Jiao, X2
Zhu, X1
Jiang, G1
Gao, J1
Li, L1

Other Studies

3 other studies available for vorinostat and Cancer of Gallbladder

ArticleYear
BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo.
    Cancer science, 2019, Volume: 110, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Divisio

2019
Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; G1 Phase Cell Cyc

2015
SAHA down-regulates the expression of indoleamine 2,3-dioxygenase via inhibition of the JAK/STAT1 signaling pathway in gallbladder carcinoma cells.
    Oncology reports, 2013, Volume: 29, Issue:1

    Topics: Antineoplastic Agents; Antiviral Agents; Blotting, Western; Gallbladder Neoplasms; Gene Expression R

2013